Because LAG-3 binding to MHC class II molecules activates myeloid cells (50), and MHC class II can be expressed by melanoma cells (51), engagement of LAG-3 with MHC class II might provide a survival signal to tumor cells. Here, LAG3 is linked to neoplasm.